Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Thyroid Neoplasms 3Thyroid Cancer, Papillary 2Adenocarcinoma, Follicular 2Thyroid Diseases 1Prostatic Neoplasms 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Hodgkin Disease 1Head and Neck Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Trastuzumab 2Iodine-131 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1pazopanib 1mercaptoundecahydrododecaborate 1copanlisib 1Vemurafenib 1Triiodothyronine 1Surgical Procedures, Operative 1Spectrum Analysis 1Rosiglitazone 1Radiofrequency Ablation 1Photochemotherapy 1Paclitaxel 1Interleukin-12 Subunit p35 1Interleukin-12 1Imatinib Mesylate 1Famotidine 1Docetaxel 1Congresses as Topic 1Bortezomib 1Azacitidine 14-boronophenylalanine-fructose 12-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Thyroid Cancer, Papillary × Iodine-131 × Clear all
NCT01413113 2015-11-05

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

University of Washington

Phase 1 Completed
6 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00004062 2013-12-19

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

National Cancer Institute (NCI)

Phase 1 Completed
EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡